70076TF480 D2S9R Rabbit Monoclonal Antibody and 3 more items

Cell Signaling Technology was awarded a contract by Virginia Commonwealth University (VCU) on June 16, 2026, with a cumulative contract value of $991.00. The contract encompasses the supply of specialized research antibodies and related reagents, consisting of four distinct line items: a D2S9R Rabbit Monoclonal Antibody ($154.70), a Platelet-Derived Growth Factor Receptor alpha D13C6 Rabbit Monoclonal Antibody ($395.25), an Anti-rabbit Immunoglobulin G Horseradish Peroxidase-linked Antibody ($172.55), and a Prostate-Specific Membrane Antigen 2 Antibody ($269.45). All materials are to be delivered to VCU Procurement in Richmond, Virginia.

This procurement supports VCU's research operations through the provision of critical molecular biology reagents essential for immunological and biochemical research applications. The contract represents a straightforward materials acquisition with fixed unit pricing and single-unit quantities across all line items, typical of academic research supply contracts. As a state institution in Virginia, VCU executed this procurement to fulfill internal laboratory and research requirements.